ICOS™ Patient-Specific Orthopedic Reconstruction Platform: When Standard Implants Are Not Enough
How AK Medical's ICOS™ platform moves from CT imaging to an executable reconstruction strategy — the design objectives, surgeon-engineer collaboration, and when patient-specific implants are appropriate versus standard components.
Standardized orthopedic implants remain the foundation of joint replacement and reconstructive surgery. In most primary procedures — and in many revision cases — established implant systems provide the right balance of availability, reproducibility, instrumentation, and clinical familiarity.
But the problem changes when anatomy no longer resembles the anatomy a standard implant was designed for. After multiple revisions, extensive osteolysis, major trauma, severe deformity, infection-related reconstruction, or tumor resection, the surgeon may no longer be asking "which implant size fits best?" The more relevant questions become:
- Where is viable host bone still available?
- Which areas can provide meaningful fixation?
- Where should the reconstructed joint center be positioned?
- Can screws reach adequate bone while avoiding critical anatomy?
- Can the planned implant actually be introduced, positioned, fixed, and assembled through the intended surgical approach?
In these cases, reconstruction may need to begin with the patient's remaining anatomy rather than a predefined implant geometry. That is the role of ICOS™ Patient-Specific Orthopedic Reconstruction.
What is ICOS™?
ICOS™ is not a single implant, and it is not simply a "3D-printed custom prosthesis." ICOS™ — Innovative Custom Orthopedic Solution — is AK Medical's patient-specific reconstruction platform. It uses structured surgeon–engineer collaboration to translate a clinical reconstruction objective into a design that can be reviewed, manufactured, and executed in the operating room:
Medical Imaging → 3D Anatomical Reconstruction → Surgeon–Engineer Collaboration → Virtual Surgical Planning → Patient-Specific Design → Engineering Verification → Additive Manufacturing → Patient-Specific Instrumentation → Surgical Execution → Case Review
The objective is not merely to create an implant that resembles the defect — it is to create a reconstruction in which fit, fixation, structural support, and surgical execution all make sense together.
Patient-specific reconstruction is not the same as 3D printing
Additive manufacturing is a manufacturing technology. Patient-specific reconstruction is a clinical and engineering strategy. A 3D-printed implant does not automatically qualify as a patient-specific implant:
| Approach | What it means | Is the permanent implant patient-specific? |
|---|---|---|
| Standard 3D-printed implant | Predefined geometry and sizes manufactured with additive manufacturing | No |
| Patient-matched solution | Existing implant options selected or configured to patient anatomy | Usually no |
| Patient-specific instrument | A cutting, drilling, positioning, or verification guide designed for one patient | Not necessarily |
| Patient-specific implant | A permanent implant designed for one patient's anatomy, defect pattern, and reconstruction objectives | Yes |
A mature patient-specific strategy does not attempt to customize everything. Where proven standard components can reliably achieve the intended reconstruction, they remain part of the solution — customization should address the parts of the problem that actually require it.
When should standard implants be preferred, and when may ICOS™ be considered?
ICOS™ is not intended to replace standard orthopedic reconstruction. When a standard acetabular cup, augment, cone, sleeve, stem, cage, or tumor reconstruction system can achieve reliable fixation and structural restoration, that standardized solution should remain the preferred option.
| Clinical situation | Standard reconstruction | ICOS™ patient-specific pathway |
|---|---|---|
| Routine primary joint replacement | Generally preferred | Usually unnecessary |
| Predictable defect treatable with standard augment/cone | Generally preferred | Usually unnecessary |
| Extensive irregular bone loss | Standard options may become limited | May be evaluated |
| Anatomy altered by multiple revisions | Standard landmarks/fixation may be compromised | 3D patient-specific planning may help |
| Limited remaining host bone | Standard fixation zones may not reach optimal bone | Fixation planned around available host bone |
| Complex or restricted screw corridors | Often dependent on standard trajectories | Screw trajectories may be planned preoperatively |
| Unusual defect after tumor resection | Standard modular reconstruction possible in selected cases | Patient-specific reconstruction may be considered |
The important distinction is not "standard versus advanced" — it is: which reconstruction strategy is appropriate for this specific clinical problem?
What is actually designed in a patient-specific implant?
A patient-specific implant should begin with design intent, not geometric complexity. An ICOS™ design needs to address several interconnected objectives:
| Design objective | Engineering question |
|---|---|
| Anatomical fit | How should the implant interface with the planned residual bone surface? |
| Host-bone contact | Which regions contain sufficient host bone to contribute to support and fixation? |
| Primary fixation | How can mechanical stability be established at implantation? |
| Screw trajectory | Where should screws be directed, and what bone should they engage? |
| Porous interface | Which surfaces are intended to interface with host bone for biological fixation? |
| Load transfer | How will loads pass from the reconstruction into remaining viable bone? |
| Component integration | How will the patient-specific structure connect with standard cups, stems, or other components? |
| Surgical execution | Can the implant be inserted, positioned, drilled, fixed, and assembled through the planned approach? |
An implant that fits a bone surface does not automatically constitute a stable reconstruction. Fixation, bone-contact regions, screw trajectories, component interfaces, and surgical feasibility must be considered together — every flange, screw hole, interface, and porous region should have a defined clinical or engineering purpose.
Surgeon and engineer roles
ICOS™ is built around disciplined surgeon–engineer collaboration, not automated decision-making.
The surgeon defines the clinical problem and intended surgical strategy: diagnosis and indication, planned resection, bone to be preserved, fixation philosophy, reconstruction objectives, surgical approach, soft-tissue considerations, and clinically acceptable risks and trade-offs.
The engineering team translates those objectives into measurable design parameters: 3D geometry, implant-to-bone contact regions, screw trajectories, porous-interface locations, connection features, patient-specific cutting or drilling guides, and manufacturing requirements.
Clinical decisions remain the responsibility of the qualified surgeon; engineering translates surgeon-approved objectives into a design and manufacturing plan — it does not replace clinical judgment.
Case in point: severe acetabular bone loss
Severe acetabular bone loss is one of the clearest examples of where patient-specific reconstruction may become relevant. Multiple revision procedures, osteolysis, implant migration, infection-related reconstruction, pelvic discontinuity, trauma, or tumor resection can substantially alter the normal acetabular architecture.
- Identify the remaining host bone. The key question is not how large the defect is — it is where the bone is that can still contribute meaningfully to fixation and structural support.
- Define the fixation strategy. Primary bone-contact regions, flange or support locations, screw number and trajectory, areas requiring structural bridging, and interfaces intended for biological fixation.
- Reconstruct hip biomechanics. The goal is not simply to occupy the defect — the reconstruction must restore hip center, joint stability, structural relationships, and load transfer.
- Confirm the reconstruction can actually be performed. Can the component pass through the planned approach? Are flange and screw positions surgically accessible? Can the planned drilling trajectories be achieved? Will guides seat reliably?
ICOS™ summarizes this principle as Fit + Fixation + Reconstruction + Execution. A design that is geometrically ideal on a computer but cannot be safely and reproducibly implanted has limited clinical value.
Tumor reconstruction starts with oncologic principles
Pelvic tumor and limb-salvage reconstruction present a different challenge from routine revision arthroplasty. The oncologic resection must be defined according to oncologic principles — not according to the shape of the implant. The implant is designed around the oncologic plan, not the other way around.
Patient-specific reconstruction may then be designed around resection planes, remaining pelvic anatomy, continuity of the pelvic ring, hip-center reconstruction, potential fixation corridors, host-bone contact, soft-tissue attachment considerations, and interfaces with standard joint components. ICOS™ may support planning and reconstruction in selected tumor cases, but it does not replace oncologic judgment, determine resection margins, or guarantee tumor control or functional outcomes.
What does "nearly 1,000 complex ICOS™ cases" mean?
AK Medical materials describe nearly 1,000 complex ICOS™ cases accumulated over more than a decade, spanning joint reconstruction, spine, trauma, and tumor-related applications. This figure does not mean every case used the same implant, followed an identical workflow, or was enrolled in a single prospective study with uniform long-term follow-up. It represents accumulated experience across different anatomical problems and design challenges — the more meaningful question is whether that experience has been translated into stronger design rules, review checklists, fixation strategies, and risk controls.
From CT imaging to an executable reconstruction
The ICOS™ pathway begins with imaging but does not end with a 3D model. Planning inputs may include thin-slice CT and, where clinically appropriate, MRI, vascular imaging, long-leg or weight-bearing radiographs, prior surgical records, and information about existing implants. The engineering team reconstructs a three-dimensional representation of remaining host bone, defects, previous implants, medullary anatomy, joint center, and relevant surgical structures — but the 3D model itself is not the surgical plan. It is a shared environment in which surgeons and engineers evaluate the reconstruction through surgeon review, geometry and interface assessment, fixation-path evaluation, manufacturability review, structural-risk assessment, manufacturing control, dimensional inspection, and applicable packaging, sterilization, and quality requirements.
The process is better described as Imaging → Clinical Intent → Engineering Design → Verification → Manufacturing → Surgical Execution — not simply "CT → 3D printing."
Frequently asked questions
Is ICOS™ an implant? No. ICOS™ is a platform and workflow. Depending on the case, the output may include planning, a patient-matched solution, a patient-specific permanent implant, surgical guides, anatomical models, or other case-specific technical support.
What is the difference between a patient-matched solution and a patient-specific implant? A patient-matched solution generally selects or configures existing implant options according to an individual patient's anatomy. A patient-specific implant is individually designed for one patient's anatomy, defect pattern, and reconstruction objectives.
Are all 3D-printed orthopedic implants patient-specific? No. Additive manufacturing is a manufacturing process. A standard acetabular component, cone, augment, or other implant may be 3D printed while remaining a standardized product.
Are patient-specific implants always better than standard implants? No. When standardized implants can achieve reliable reconstruction, they remain an important and often preferable option. Patient-specific implants address selected problems that cannot be adequately solved with standard configurations.
Medical and regulatory notice: ICOS™-related patient-matched solutions, patient-specific instruments, and patient-specific implants may have different indications, materials, configurations, manufacturing requirements, and regulatory pathways across countries and regions. This article does not imply that every ICOS™ product, instrument, indication, or configuration is commercially available or authorized in every market. Clinical use should be based on applicable local regulatory clearances or registrations, product labeling, Instructions for Use, case-specific design review, institutional requirements, and the judgment of the treating healthcare professional.
Related AK Medical products
